NNC 0151-0000-0000 / Novo Nordisk - LARVOL DELTA

An Investigation of NNC 0151-0000-0000 in Subjects With Systemic Lupus Erythematosus (SLE) (clinicaltrials.gov) - P1; N=0; Withdrawn; Sponsor: Novo Nordisk A/S; Terminated -> Withdrawn

Trial withdrawal • Biosimilar • Immunology • Lupus • Reperfusion Injury